- For Patients
- Introduction to the Marshall Protocol
- Length of the MP
- Immunopathology
- Managing immunopathology
- Food and drink
- Light restriction
- Vitamin D metabolite calculator - get feedback on vitamin D results
- Therapeutic probe - best method for determining MP suitability
- Starting the Marshall Protocol
- Resources for patients
- Marshall Protocol summary
- Palliative vs. curative treatments
- Patient interviews on Bacteriality
- Non-MP treatments
- Glossary
- The Protocol
- Marshall Protocol summary
- Publications and presentations
- Science behind immunopathology
- Science behind olmesartan (Benicar)
- Safety of olmesartan
- Resources for physicians
- Vitamin D metabolite calculator - get feedback on vitamin D results
- Therapeutic probe - best method for determining MP suitability
- Physicians' concerns about the MP
- Notice for emergency medical personnel
- The Pathogenesis
- Publications and presentations
- Science behind Marshall Pathogenesis
- Microbes in the human body
- Successive infection and variability in disease
- Autoimmune theory of disease
- Science behind vitamin D
- Metabolism of vitamin D and the VDR
- Th1 Spectrum Disorder - how chronic inflammatory diseases are related
- Transmission of bacteria and onset of chronic disease
- Evolutionary perspective on disease
- Incidence and prevalence of disease
- Evidence that chronic disease is caused by pathogens
- Diseases
- Foundation
- Related Sites
Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revision | Next revisionBoth sides next revision | ||
| home:othertreatments:antibacterials [10.20.2016] – [Curative treatments must generate immunopathology] sallieq | home:othertreatments:antibacterials [07.04.2017] – [Non-MP antibacterials] + Cephalosporins to de-emphasize fluoroquinoloness sallieq | ||
|---|---|---|---|
| Line 5: | Line 5: | ||
| Those antibiotics which may be used for periods of time with the Marshall Protocol (MP) have been carefully selected for their effectiveness and safety. A number of other antibacterials have been proposed in the treatment of chronic disease. Some of these such as high-dose doxycycline fail to target all the bacteria responsible for the Th1 diseases. Others such as ceftriaxone (Rocephin) exert a short-term immunosuppressive effect and actually contribute to the growth of the very bacterial forms the MP attempts to eradicate. | Those antibiotics which may be used for periods of time with the Marshall Protocol (MP) have been carefully selected for their effectiveness and safety. A number of other antibacterials have been proposed in the treatment of chronic disease. Some of these such as high-dose doxycycline fail to target all the bacteria responsible for the Th1 diseases. Others such as ceftriaxone (Rocephin) exert a short-term immunosuppressive effect and actually contribute to the growth of the very bacterial forms the MP attempts to eradicate. | ||
| - | For reasons ranging from prophylaxis to acute infections, Marshall Protocol (MP) are sometimes advised to take an antibiotic different from the ones compatible with the MP. Under special circumstances, | + | For reasons ranging from prophylaxis to acute infections, Marshall Protocol (MP) are sometimes advised to take an antibiotic different from the ones compatible with the MP. Under special circumstances, |
| + | |||
| + | Cephalosporins, | ||
home/othertreatments/antibacterials.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.